1. Product
Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research
Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive
Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key Market
Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4. Voice
of Customer
5. Clinical
Trial Analysis
5.1. Ongoing
Clinical Trials
5.2. Completed
Clinical Trials
5.3. Terminated
Clinical Trials
5.4. Breakdown
of Pipeline, By Development Phase
5.5. Breakdown
of Pipeline, By Status
5.6. Breakdown
of Pipeline, By Study Type
5.7. Breakdown
of Pipeline, By Region
5.8. Clinical
Trials Heat Map
6.
Global Transcriptomics Market Outlook
6.1. Market
Size & Forecast
6.1.1. By
Value
6.2. Market
Share & Forecast
6.2.1.
By Component (Instruments, Consumables,
Software & Services)
6.2.2.
By Technology (Next Generation Sequencing,
Polymerase Chain Reaction, Microarray, In-Situ Hybridization, Others)
6.2.3.
By Application (Drug Discovery &
Development, Cell Biology, Single Cell Analysis, Gene Expression, Others)
6.2.4.
By End User (Biotechnology &
Pharmaceutical Companies, Academic & Research Institutions, Others)
6.2.5.
By Region
6.2.6. By
Company (2022)
6.3. Market
Map
6.3.1. By
Component
6.3.2. By
Technology
6.3.3. By
Application
6.3.4. By End
User
6.3.5. By
Region
7.
North America Transcriptomics
Market Outlook
7.1. Market
Size & Forecast
7.1.1. By
Value
7.2. Market
Share & Forecast
7.2.1.
By Component
7.2.2.
By Technology
7.2.3.
By Application
7.2.4.
By End User
7.2.5. By
Country
7.3. North
America: Country Analysis
7.3.1. United
States Transcriptomics Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Component
7.3.1.2.2.
By Technology
7.3.1.2.3.
By Application
7.3.1.2.4.
By End User
7.3.2. Canada
Transcriptomics Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Component
7.3.2.2.2.
By Technology
7.3.2.2.3.
By Application
7.3.2.2.4.
By End User
7.3.3. Mexico
Transcriptomics Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Component
7.3.3.2.2.
By Technology
7.3.3.2.3.
By Application
7.3.3.2.4.
By End User
8.
Europe Transcriptomics Market Outlook
8.1. Market
Size & Forecast
8.1.1. By
Value
8.2. Market
Share & Forecast
8.2.1.
By Component
8.2.2.
By Technology
8.2.3.
By Application
8.2.4.
By End User
8.2.5.
By Country
8.3. Europe:
Country Analysis
8.3.1. France
Transcriptomics Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Component
8.3.1.2.2.
By Technology
8.3.1.2.3.
By Application
8.3.1.2.4.
By End User
8.3.2. Germany
Transcriptomics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Component
8.3.2.2.2.
By Technology
8.3.2.2.3.
By Application
8.3.2.2.4.
By End User
8.3.3. United
Kingdom Transcriptomics Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Component
8.3.3.2.2.
By Technology
8.3.3.2.3.
By Application
8.3.3.2.4.
By End User
8.3.4. Italy
Transcriptomics Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Component
8.3.4.2.2.
By Technology
8.3.4.2.3.
By Application
8.3.4.2.4.
By End User
8.3.5. Spain
Transcriptomics Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Component
8.3.5.2.2.
By Technology
8.3.5.2.3.
By Application
8.3.5.2.4.
By End User
9.
Asia-Pacific Transcriptomics
Market Outlook
9.1. Market
Size & Forecast
9.1.1. By
Value
9.2. Market
Share & Forecast
9.2.1.
By Component
9.2.2.
By Technology
9.2.3.
By Application
9.2.4.
By End User
9.2.5. By
Country
9.3. Asia-Pacific:
Country Analysis
9.3.1. China
Transcriptomics Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Component
9.3.1.2.2.
By Technology
9.3.1.2.3.
By Application
9.3.1.2.4.
By End User
9.3.2. India
Transcriptomics Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Component
9.3.2.2.2.
By Technology
9.3.2.2.3.
By Application
9.3.2.2.4.
By End User
9.3.3. Japan
Transcriptomics Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Component
9.3.3.2.2.
By Technology
9.3.3.2.3.
By Application
9.3.3.2.4.
By End User
9.3.4. South
Korea Transcriptomics Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Component
9.3.4.2.2.
By Technology
9.3.4.2.3.
By Application
9.3.4.2.4.
By End User
9.3.5. Australia
Transcriptomics Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Component
9.3.5.2.2.
By Technology
9.3.5.2.3.
By Application
9.3.5.2.4.
By End User
10. South
America Transcriptomics Market Outlook
10.1.
Market Size & Forecast
10.1.1. By
Value
10.2.
Market Share & Forecast
10.2.1.
By Component
10.2.2.
By Technology
10.2.3.
By Application
10.2.4.
By End User
10.2.5. By
Country
10.3.
South America: Country Analysis
10.3.1. Brazil
Transcriptomics Market Outlook
10.3.1.1. Market
Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market
Share & Forecast
10.3.1.2.1.
By Component
10.3.1.2.2.
By Technology
10.3.1.2.3.
By Application
10.3.1.2.4.
By End User
10.3.2. Argentina
Transcriptomics Market Outlook
10.3.2.1. Market
Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market
Share & Forecast
10.3.2.2.1.
By Component
10.3.2.2.2.
By Technology
10.3.2.2.3.
By Application
10.3.2.2.4.
By End User
10.3.3. Colombia
Transcriptomics Market Outlook
10.3.3.1. Market
Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market
Share & Forecast
10.3.3.2.1.
By Component
10.3.3.2.2.
By Technology
10.3.3.2.3.
By Application
10.3.3.2.4.
By End User
11. Middle
East and Africa Transcriptomics Market Outlook
11.1.
Market Size & Forecast
11.1.1. By
Value
11.2.
Market Share & Forecast
11.2.1.
By Component
11.2.2.
By Technology
11.2.3.
By Application
11.2.4.
By End User
11.2.5. By
Country
11.3.
MEA: Country Analysis
11.3.1. South
Africa Transcriptomics Market Outlook
11.3.1.1. Market
Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market
Share & Forecast
11.3.1.2.1.
By Component
11.3.1.2.2.
By Technology
11.3.1.2.3.
By Application
11.3.1.2.4.
By End User
11.3.2. Saudi
Arabia Transcriptomics Market Outlook
11.3.2.1. Market
Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market
Share & Forecast
11.3.2.2.1.
By Component
11.3.2.2.2.
By Technology
11.3.2.2.3.
By Application
11.3.2.2.4.
By End User
11.3.3. UAE Transcriptomics
Market Outlook
11.3.3.1. Market
Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market
Share & Forecast
11.3.3.2.1.
By Component
11.3.3.2.2.
By Technology
11.3.3.2.3.
By Application
11.3.3.2.4.
By End User
11.3.4. Turkey
Transcriptomics Market Outlook
11.3.4.1. Market
Size & Forecast
11.3.4.1.1.
By Value
11.3.4.2. Market
Share & Forecast
11.3.4.2.1.
By Component
11.3.4.2.2.
By Technology
11.3.4.2.3.
By Application
11.3.4.2.4.
By End User
11.3.5. Egypt
Transcriptomics Market Outlook
11.3.5.1. Market
Size & Forecast
11.3.5.1.1.
By Value
11.3.5.2. Market
Share & Forecast
11.3.5.2.1.
By Component
11.3.5.2.2.
By Technology
11.3.5.2.3.
By Application
11.3.5.2.4.
By End User
12. Market
Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market
Trends & Developments
13.1.
Recent Developments
13.2.
Mergers & Acquisitions
13.3.
Product Launches
14. Competitive
Landscape
14.1.
Business Overview
14.2.
Product Offerings
14.3.
Recent Developments
14.4.
Financials (As Reported)
14.5.
Key Personnel
14.6.
SWOT Analysis
14.6.1. Agilent
Technologies, Inc.
14.6.2. ANGLE
plc.
14.6.3. Bio-Rad
Laboratories, Inc.
14.6.4. Becton,
Dickinson, and Company
14.6.5. Fluidigm
Corporation
14.6.6. BioSypder,
Inc.
14.6.7. Danaher
Corporation (Cytiva)
14.6.8. 10x
Genomics, Inc.
14.6.9. Pacific
Biosciences of California, Inc.
14.6.10.
NanoString Technologies, Inc.
Strategic
Recommendations